(Q51310737)

English

Anagliptin and sitagliptin as add-ons to metformin for patients with type 2 diabetes: a 24-week, multicentre, randomized, double-blind, active-controlled, phase III clinical trial with a 28-week extension.

scientific article published on 14 January 2015

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25523633%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Anagliptin and sitagliptin as add-ons to metformin for patients with type 2 diabetes: a 24-week, multicentre, randomized, double-blind, active-controlled, phase III clinical trial with a 28-week extension (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25523633%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

type 2 diabetes

0 references

phase III clinical trial

0 references

multicenter clinical trial

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Choon Hee Chung

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25523633%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

author name string

S-M Jin

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25523633%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

S W Park

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25523633%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

K-H Yoon

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25523633%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

K W Min

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25523633%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

K-H Song

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25523633%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

K S Park

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25523633%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

J-Y Park

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25523633%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

I B Park

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25523633%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

S H Baik

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25523633%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

S H Choi

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25523633%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

H W Lee

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25523633%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

I-K Lee

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25523633%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

D-M Kim

14

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25523633%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

M-K Lee

15

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25523633%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

publication date

14 January 2015

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25523633%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Diabetes, Obesity and Metabolism

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25523633%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

17

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25523633%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25523633%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

511-515

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25523633%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Preclinical and clinical aspects of the dipeptidyl peptidase-4 inhibitor anagliptin

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12429

21 January 2018

Pharmacokinetics and metabolism of [14C]anagliptin, a novel dipeptidyl peptidase-4 inhibitor, in humans

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12429

21 January 2018

Efficacy and safety of the dipeptidyl peptidase-4 inhibitor gemigliptin compared with sitagliptin added to ongoing metformin therapy in patients with type 2 diabetes inadequately controlled with metformin alone.

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12429

21 January 2018

Differences in the glucose-lowering efficacy of dipeptidyl peptidase-4 inhibitors between Asians and non-Asians: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12429

21 January 2018

Efficacy, safety and dose-response relationship of teneligliptin, a dipeptidyl peptidase-4 inhibitor, in Japanese patients with type 2 diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12429

21 January 2018

Predictive clinical parameters for the therapeutic efficacy of sitagliptin in korean type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12429

21 January 2018

Factors predicting therapeutic efficacy of combination treatment with sitagliptin and metformin in type 2 diabetic patients: the COSMETIC study.

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12429

21 January 2018

Continuous glucose profiles with vildagliptin versus sitagliptin in add-on to metformin: results from the randomized Optima study

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12429

21 January 2018

Comparison of vildagliptin twice daily vs. sitagliptin once daily using continuous glucose monitoring (CGM): crossover pilot study (J-VICTORIA study).

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12429

21 January 2018

Discovery and pharmacological characterization of N-[2-({2-[(2S)-2-cyanopyrrolidin-1-yl]-2-oxoethyl}amino)-2-methylpropyl]-2-methylpyrazolo[1,5-a]pyrimidine-6-carboxamide hydrochloride (anagliptin hydrochloride salt) as a potent and selective DPP-IV

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12429

21 January 2018

Identifiers

10.1111/DOM.12429

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25523633%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25523633%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51310737&oldid=1239294517"